Literature DB >> 1126780

A comparative clinical evaluation of trimethylpsoralen, psoralen and 8-methoxypsoralen in treating vitiligo.

V N Sehgal.   

Abstract

Trimethylpsoralen, psoralen and 8-methoxypsoralen were adminstered in 10 mg dosage orally to 37, 29 and 23 patients with vitiligo. Complete improvement was noted in 8.9% and partial improvement was recorded in 59.5%. The overall results produced by trimethylpsoralen and psoralen were superior to those of 8-methoxypsoralen. There was no significant therapeutic difference noticed in regards to age, sex, duration and type of vitiligo.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 1126780     DOI: 10.1111/ijd.1975.14.3.205

Source DB:  PubMed          Journal:  Int J Dermatol        ISSN: 0011-9059            Impact factor:   2.736


  3 in total

1.  Replication bypass model of sister chromatid exchanges and implications for Bloom's syndrome and Fanconi's anemia.

Authors:  D A Shafer
Journal:  Hum Genet       Date:  1977-11-10       Impact factor: 4.132

2.  8-Methoxypsoralen is a competitive inhibitor of glutathione S-transferase P1-1.

Authors:  Diêgo Madureira de Oliveira; Marcel Tavares de Farias; André Lacerda Braga Teles; Manoelito Coelho Dos Santos Junior; Martins Dias de Cerqueira; Rute Maria Ferreira Lima; Ramon Santos El-Bachá
Journal:  Front Cell Neurosci       Date:  2014-09-30       Impact factor: 5.505

Review 3.  The Safety of Medicinal Plants Used in the Treatment of Vitiligo and Hypermelanosis: A Systematic Review of Use and Reports of Harm.

Authors:  Irshad Hussain
Journal:  Clin Cosmet Investig Dermatol       Date:  2021-03-23
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.